These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6365657)

  • 21. Inhibition of carbohydrate-induced hypertriglyceridemia by a disaccharidase inhibitor.
    Zavaroni I; Reaven GM
    Metabolism; 1981 Apr; 30(4):417-20. PubMed ID: 7010078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of sucrose meal on insulin requirement in IDDM and its modulation by acarbose.
    Lecavalier L; Hamet P; Chiasson JL
    Diabete Metab; 1986 Jun; 12(3):156-61. PubMed ID: 3525270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
    Santeusanio F; Compagnucci P
    Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release.
    Enç FY; Imeryüz N; Akin L; Turoğlu T; Dede F; Haklar G; Tekeşin N; Bekiroğlu N; Yeğen BC; Rehfeld JF; Holst JJ; Ulusoy NB
    Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G752-63. PubMed ID: 11518688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study.
    Ruppin H; Hagel J; Feuerbach W; Schutt H; Pichl J; Hillebrand I; Bloom S; Domschke W
    Gastroenterology; 1988 Jul; 95(1):93-9. PubMed ID: 3286363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Acarbose--a new therapeutic principle in diabetes mellitus therapy].
    Schöffling K; Hillebrand I
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term treatment in diabetics with acarbose, a glucosidase inhibitor: efficacy, tolerability and effect on GI hormones.
    Hillebrand I; Aubell R; Boehme K; Bloom SR; Berchtold P
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():683-6. PubMed ID: 6393444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of weight gain by an alpha-glucosidase inhibitor during refeeding in rats.
    Kotler DP; Tierney AR; Kral JG; Bjorntorp P
    Am J Clin Nutr; 1984 Aug; 40(2):270-6. PubMed ID: 6380264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of alpha-glucosidase inhibition on intestinal disaccharidase activity in normal and diabetic mice.
    Lee SM; Bustamante SA; Koldovský O
    Metabolism; 1983 Aug; 32(8):793-9. PubMed ID: 6346004
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacology of alpha-glucosidase inhibition.
    Bischoff H
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():3-10. PubMed ID: 8001624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of glycemic and hormonal responses after repetitive sucrose and starch loads by different doses of the alpha-glucosidase inhibitor miglitol (BAY m 1099) in man.
    Lembcke B; Fölsch UR; Gatzemeier W; Ebert R; Siegel E; Creutzfeldt W
    Pharmacology; 1991; 43(6):318-28. PubMed ID: 1784628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acarbose reduces blood pressure in sucrose-induced hypertension in rats.
    Madar Z; Melamed EC; Zimlichman R
    Isr J Med Sci; 1997 Mar; 33(3):153-9. PubMed ID: 9313782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome.
    Lyons TJ; McLoughlin JC; Shaw C; Buchanan KD
    Digestion; 1985; 31(2-3):89-96. PubMed ID: 3888753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man.
    Scheen AJ; de Magalhaes AC; Salvatore T; Lefebvre PJ
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():50-4. PubMed ID: 7818725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of acarbose on the 24-hour blood glucose profile and pattern of carbohydrate absorption.
    Taylor RH; Jenkins DJ; Barker HM; Fielden H; Goff DV; Misiewicz JJ; Lee DA; Allen HB; MacDonald G; Wallrabe H
    Diabetes Care; 1982; 5(2):92-6. PubMed ID: 6927727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Nutrient digestibility and N-balance after administration of an alpha-glucosidase inhibitor to pigs].
    Roth FX; Kirchgessner M
    Z Tierphysiol Tierernahr Futtermittelkd; 1980; 44(2):57-63. PubMed ID: 6252715
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421).
    Krause HP; Keup U; Thomas G; Puls W
    Metabolism; 1982 Jul; 31(7):710-4. PubMed ID: 7045575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
    Hücking K; Kostic Z; Pox C; Ritzel R; Holst JJ; Schmiegel W; Nauck MA
    Diabet Med; 2005 Apr; 22(4):470-6. PubMed ID: 15787675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
    Hayakawa T; Noda A; Kondo T; Okumura N
    Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of sucrose- and starch-induced glycaemic and hormonal responses by the alpha-glucosidase inhibitor emiglitate (BAY o 1248) in healthy volunteers.
    Lembcke B; Fölsch UR; Gatzemeier W; Lücke B; Ebert R; Siegel E; Creutzfeldt W
    Eur J Clin Pharmacol; 1991; 41(6):561-7. PubMed ID: 1815967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.